Autograft
Autograft is an intervention with 13 clinical trials. Currently 1 active trials ongoing. Historical success rate of 50.0%.
Success Metrics
Based on 3 completed trials
Phase Distribution
Phase Distribution
0
Early Stage
2
Mid Stage
2
Late Stage
Highest Phase Reached
Phase 4Trial Status & Enrollment
37.5%
3 of 8 finished
62.5%
5 ended early
1
trials recruiting
13
all time
Detailed Status
Development Timeline
Analytics
Development Status
Trials by Phase
Trials by Status
Recent Activity
A Prospective, Randomized, Single-blind, Controlled, Multi-center Study to Assess the Safety and Performance of MagnetOsTM Compared to Autogenous Bone Graft in Patients Undergoing Hindfoot or Ankle Fusions.
Allograft vs. Autograft Nonunion
Evaluating Whether Intact Fish Skin Graft Can Decrease the Need for Autograft in the Treatment of Deep Partial-Thickness Burns
BMAC & Allograft vs BMP-2
Evaluation of Cranioplasty Using Native Bone Autograft Versus Synthetic Bone Allograft
Clinical Trials (13)
A Prospective, Randomized, Single-blind, Controlled, Multi-center Study to Assess the Safety and Performance of MagnetOsTM Compared to Autogenous Bone Graft in Patients Undergoing Hindfoot or Ankle Fusions.
Allograft vs. Autograft Nonunion
Evaluating Whether Intact Fish Skin Graft Can Decrease the Need for Autograft in the Treatment of Deep Partial-Thickness Burns
BMAC & Allograft vs BMP-2
Evaluation of Cranioplasty Using Native Bone Autograft Versus Synthetic Bone Allograft
Comparing Efficacy of Bone Marrow Aspirate Concentrate (BMAC) Combined With Allograft in Treatment of Calcaneus Fractures
COMPARATIVE ANALYSIS OF INNOVATIVE BONE HEALING TECHNIQUES
StrataGraft® Skin Tissue as an Alternative to Autografting Full-thickness Complex Skin Defects
StrataGraft® Skin Tissue in the Promotion of Autologous Skin Regeneration of Complex Skin Defects Due to Thermal Burns That Contain Intact Dermal Elements
Comparison of Bioactive Glass and Beta-Tricalcium Phosphate as Bone Graft Substitute
Comparison of Skin Substitutes Used in Burn Care
Indication to Transplant Patients With High Risk B Cells Lymphoma in Metabolic Complete Remission?
NanOss Bioactive With Autograft and Bone Marrow Aspirate in the Posterolateral Spine
All 13 trials loaded
Drug Details
- Intervention Type
- OTHER
- Total Trials
- 13